Vanderbilt University Medical Center, Clinical Trials Center Vanderbilt UMC is a clinical research site located in Nashville, Tennessee, United States 37212.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
Vanderbilt University Medical Center, Clinical Trials Center Vanderbilt UMC has participated in 1 clinical trials.
Therapeutic areas: Relapsed and Bortezomib Refractory Multiple Myeloma, Refractory Multiple Myeloma, Multiple Myeloma in Relapse.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Vanderbilt University Medical Center, Clinical Trials Center Vanderbilt UMC has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Vanderbilt University Medical Center, Clinical Trials Center Vanderbilt UMC has 1 clinical trials on record. Their work covers Relapsed and Bortezomib Refractory Multiple Myeloma, Refractory Multiple Myeloma, Multiple Myeloma in Relapse.
Vanderbilt University Medical Center, Clinical Trials Center Vanderbilt UMC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.